Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 551 - 575 of 808 in total
Alfaxalone, also known as alphaxalone or alphaxolone, is a neuroactive steroid and general anaesthetic. It is used in veterinary practice under the trade name Alfaxan, and is licensed for use in both dogs and cats. Along with alfadolone, it is also one of the constituents of anesthetic drug mixture althesin.
Vet approved
ARX201 (PEG-ahGH) is a recombinant form of human growth hormone that has been modified using Ambrx’s patented ReCODE™ technology to achieve precise spatial positioning of the site of polyethylene glycol (PEG) attachment to human growth hormone, by biosynthetic incorporation of a chemically unique amino acid (ahGH). ARX201 has improved pharmacological...
Investigational
Matched Description: … ARX201 (PEG-ahGH) is a recombinant form of human growth hormone that has been modified using Ambrx’s ... achieve precise spatial positioning of the site of polyethylene glycol (PEG) attachment to human growth hormone
Balugrastim has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Categories: … Colony-Stimulating Factors …
SR 121463 is a nonpeptide aquaretic compound with potent selective antagonism of the vasopressin V2 (V1b) receptor subtype. It is a candidate for control of hyponatremia and in the treatment of syndrome of inappropriate secretion of anti-diuretic hormone (SIADH).
Investigational
Matched Description: … control of hyponatremia and in the treatment of syndrome of inappropriate secretion of anti-diuretic hormone
A 6-methyl progesterone acetate with reported glucocorticoid activity and effect on estrus.
Experimental
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists …
Eftansomatropin alfa (GX-H9) comprises a recombinant human growth hormone fused to hyFc, a synthetic hybrid Fc fragment. It is under investigation for the treatment of growth hormone deficiency.
Investigational
Matched Description: … [L48275] It is under investigation for the treatment of growth hormone deficiency. ... Eftansomatropin alfa (GX-H9) comprises a recombinant human growth hormone fused to hyFc, a synthetic …
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists ... Growth Hormone
MF101 is a novel estrogen receptor beta (ERβ) selective agonist and unlike currently available hormone therapies, does not activate the estrogen receptor alpha (ERα), known to be implicated in tumor formation. MF101 is an oral drug designed for the treatment of hot flashes and night sweats in peri-menopausal and menopausal...
Investigational
Matched Description: … MF101 is a novel estrogen receptor beta (ERβ) selective agonist and unlike currently available hormone
GlycoPEG-GCSF is a long-acting GlycoPEGylated granulocyte colony stimulating factor for the treatment of chemotherapy-induced neutropenia.
Investigational
Matched Description: … GlycoPEG-GCSF is a long-acting GlycoPEGylated granulocyte colony stimulating factor for the treatment …
ORG-31710 is a progestational hormone antagonist.
Experimental
Matched Description: … ORG-31710 is a progestational hormone antagonist. …
TPIV 200 is a vaccine consisting of proteins from the folate receptor alpha mixed with Granulocyte-macrophage colony-stimulating factor (GM-CSF).
Investigational
Matched Description: … vaccine consisting of proteins from the folate receptor alpha mixed with Granulocyte-macrophage colony-stimulating
Tigapotide is a synthetic 15-mer peptide that is derived from the natural sequence of amino acids of the prostate secretory protein (PSP94), one of three predominant proteins found in human seminal fluid.
Investigational
MAXY-G34 is a pegylated variant of human granulocyte-colony stimulating factor (G-CSF). This variant contains multiple non-naturally occurring lysines that have been introduced into alpha helixes of wild type human G-CSF as PEGylation sites, and from which multiple undesired, naturally occurring lysines have been removed as compared to wild type human...
Investigational
Matched Description: … MAXY-G34 is a pegylated variant of human granulocyte-colony stimulating factor (G-CSF). …
Matched Categories: … Colony-Stimulating Factors …
JAK4D is a first-in-class thyrotropin-releasing hormone (TRH)-based compound.
Investigational
Matched Description: … JAK4D is a first-in-class thyrotropin-releasing hormone (TRH)-based compound. …
Gemogenovatucel-T is a bi-shRNA furin/Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented autologous tumour cell vaccine. Furin is a convertase involved in the activation of TGFβ-1 and TGFβ-2. Gemogenovatucel-T is being investigated in the treatment of various cancers.
Investigational
Matched Description: … Gemogenovatucel-T is a bi-shRNA furin/Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented …
SynOV1.1 is an investigational cancer immunotherapy developed by SyngenTech. It is a recombinant oncolytic adenovirus, controlled by synthetic gene circuit, encoding the human immunostimulating factor cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF). SynOV1.1 is under investigation in clinical trial NCT04612504 (Synov1.1 Intratumoral Injection Study).
Investigational
Matched Description: … synthetic gene circuit, encoding the human immunostimulating factor cytokine granulocyte-macrophage colony-stimulating
Acyline has been investigated for the prevention and treatment of Hypogonadism and Contraception.
Investigational
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists ... Hormone Antagonists ... Gonadotropin-Releasing Hormone, antagonists & inhibitors …
Vapreotide is a synthetic octapeptide somatostatin analog. It was being studied for the treatment of cancer.
Experimental
Investigational
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists ... Pituitary Hormone Release Inhibiting Hormones …
A synthetic decapeptide, water-soluble Gonadotropin-releasing hormone antagonist. It has reached phase II clinical trials.
Investigational
Matched Description: … A synthetic decapeptide, water-soluble Gonadotropin-releasing hormone antagonist. …
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists ... Hormone Antagonists …
Ormeloxifene is a third-generation selective estrogen receptor (ER) modulator. In India, ormeloxifene has been marketed since the 1990s as a non-hormonal, non-steroidal oral contraceptive taken once a week, and it was later introduced for the treatment of dysfunctional uterine bleeding. Similar to other selective estrogen receptor modulators (SERMs), ormeloxifene has...
Experimental
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists ... Hormone Antagonists …
Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent.
Investigational
Matched Description: … Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent …
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists …
Somavaratan has been used in trials studying the treatment of Growth Disorders and Adult Growth Hormone Deficiency.
Investigational
Matched Description: … Somavaratan has been used in trials studying the treatment of Growth Disorders and Adult Growth Hormone
Deslorelin acetate is an injectable gonadotropin releasing hormone super-agonist also known as an LHRH agonist. It stops the production of sex hormones.
Investigational
Vet approved
Matched Description: … Deslorelin acetate is an injectable gonadotropin releasing hormone super-agonist also known as an LHRH …
Matched Categories: … Hormones, Hormone Substitutes, and Hormone Antagonists ... Gonadotropin-releasing hormone agonist ... Pituitary Hormone-Releasing Hormones …
MBX-2109 is a long-acting parathyroid hormone peptide prodrug under investigation for the treatment of hyperparathyroidism.
Investigational
Matched Description: … MBX-2109 is a long-acting parathyroid hormone peptide prodrug under investigation for the treatment of …
NRP409 is a triiodothyronine (T3) hormone, being investigated by New River Pharmaceuticals as a treatment for patients with primary hypothyroidism.
Investigational
Matched Description: … NRP409 is a triiodothyronine (T3) hormone, being investigated by New River Pharmaceuticals as a treatment …
Displaying drugs 551 - 575 of 808 in total